Skip to main content
. 2019 May 30;12:4287–4295. doi: 10.2147/OTT.S195853

Figure 4.

Figure 4

FENDRR-mediated SOX4 repression attenuated the progression of colon cancer in vitro.

Notes: (A) Western blot analysis of SOX4 expression in SOX4-overexpressing cells with or without transient expression of FENDRR. (B) Cell viability, (C) invasive ability and (D) changes of epithelial–mesenchymal transition (EMT) phenotype were observed in SOX4-overexpressing cells with or without transient expression of FENDRR. *p or #p<0.05, **p or ##p<0.01, ***p or ###p<0.001 (SOX4 versus vector or SOX4+FENDRR, respectively).